Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone-Reference-Cited by-同舟云学术

Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone

Published:1994-05 Issue:2 Volume:25 Page:75-82
ISSN:0169-6009
Container-title:Bone and Mineral
language:en
Short-container-title:Bone and Mineral

Author:

Adami S.,Zamberlan N.,Mian M.,Dorizzi R.,Rossini M.,Braga B.,Gatti D.,Bertoldo F.,Locascio V.

Publisher

Elsevier BV

Subject

Endocrinology,Biochemistry,Surgery

Reference15 articles.

1. Bisphosphonates. Pharmacology and use in the treatment of tumour induced hypercalcaemic and metastatic bone disease;Fleisch;Drugs,1991

2. Treatment of Paget's disease;Cantrill;Clin Endocrinol,1990

3. Duration of effect of oral disphosphonate therapy in Paget's disease of bone;Gray;Q J Med,1987

4. Efficacious management with aminobisphosphonate (APD) of Paget's disease of bone;Harinck;Clin Orthop Rel Res,1987

5. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone;Thiebaud;Am J Med,1988

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Various Forms of Local Drug Delivery Systems on a Class 2 Furcation – A Systematic Review;Journal of Pharmacy and Bioallied Sciences;2023-07

2. Menopause and care of the mature woman;Comprehensive Gynecology;2022

3. Menopause and Aging;Yen and Jaffe's Reproductive Endocrinology;2019

4. Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers;Journal of Applied Oral Science;2017-06

5. Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review;Frontiers in Endocrinology;2017-04-20